Milwaukee Capital Partners completed the acquisition of MPP Group.

Milwaukee Capital Partners, a private equity firm, completed the acquisition of MPP Group, a company focused on development and formulations of injectable drug products. Financial terms were not disclosed. "With a burgeoning focus on repatriating pharmaceutical development and manufacturing into the US, we believe that MPP is well positioned for partnering with pharma and biotech both domestically and internationally to capitalize on these opportunities," Thomas Kintis, Milwaukee Capital Partners Managing Partner.